Indian Journal of Clinical Biochemistry

, Volume 25, Issue 3, pp 225–243 | Cite as

Reconvene and Reconnect the Antioxidant Hypothesis in Human Health and Disease

  • P. P. Singh
  • Anu Chandra
  • Farzana Mahdi
  • Ajanta Roy
  • Praveen Sharma
Review Article


The antioxidants are essential molecules in human system but are not miracle molecules. They are neither performance enhancers nor can prevent or cure diseases when taken in excess. Their supplemental value is debateable. In fact, many high quality clinical trials on antioxidant supplement have shown no effect or adverse outcomes ranging from morbidity to all cause mortality. Several Chochrane Meta-analysis and Markov Model techniques, which are presently best available statistical models to derive conclusive answers for comparing large number of trials, support these claims. Nevertheless none of these statistical techniques are flawless. Hence, more efforts are needed to develop perfect statistical model to analyze the pooled data and further double blind, placebo controlled interventional clinical trials, which are gold standard, should be implicitly conducted to get explicit answers. Superoxide dismutase (SOD), glutathione peroxidase and catalase are termed as primary antioxidants as these scavenge superoxide anion and hydrogen peroxide. All these three enzymes are inducible enzymes, thereby inherently meaning that body increases or decreases their activity as per requirement. Hence there is no need to attempt to manipulate their activity nor have such efforts been clinically useful. SOD administration has been tried in some conditions especially in cancer and myocardial infarction but has largely failed, probably because SOD is a large molecule and can not cross cell membrane. The dietary antioxidants, including nutrient antioxidants are chain breaking antioxidants and in tandem with enzyme antioxidants temper the reactive oxygen species (ROS) and reactive nitrogen species (RNS) within physiological limits. Since body is able to regulate its own requirements of enzyme antioxidants, the diet must provide adequate quantity of non-enzymic antioxidants to meet the normal requirements and provide protection in exigent condition. So far, there is no evidence that human tissues ever experience the torrent of reactive species and that in chronic conditions with mildly enhanced generation of reactive species, the body can meet them squarely if antioxidants defense system in tissues is biochemically optimized. We are not yet certain about optimal levels of antioxidants in tissues. Two ways have been used to assess them: first by dietary intake and second by measuring plasma levels. Lately determination of plasma/serum level of antioxidants is considered better index for diagnostic and prognostic purposes. The recommended levels for vitamin A, E and C and beta carotene are 2.2–2.8 μmol/l; 27.5–30 μmol/l; 40–50 μmol/l and 0.4–0.5 μmol/l, respectively. The requirement and recommended blood levels of other dietary antioxidants are not established. The resolved issues are (1) essential to scavenge excess of radical species (2) participants in redox homeostasis (3) selective antioxidants activity against radical species (4) there is no universal antioxidant and 5) therapeutic value in case of deficiency. The overarching issues are (1) therapeutic value as adjuvant therapy in management of diseases (2) supplemental value in developing population (3) selective interactivity of antioxidant in different tissues and on different substrates (4) quantitative contribution in redox balance (5) mechanisms of adverse action on excess supplementation (6) advantages and disadvantages of prooxidant behavior of antioxidants (7) behavior in cohorts with polymorphic differences (8) interaction and intervention in radiotherapy, diabetes and diabetic complications and cardiovascular diseases (9) preventive behavior in neurological disorders (10) benefits of non-nutrient dietary antioxidants (11) markers to assess optimized antioxidants status (12) assessment of benefits of supplementation in alcoholics and heavy smokers. The unresolved and intriguing issues are (1) many compounds such as vitamin A and many others possessing both antioxidant and non-antioxidant properties contribute to both the activities in vivo or exclusively only to non-antioxidant activity and (2) since human tissues do not experience the surge of FR, whether there is any need to develop stronger synthetic antioxidants. Theoretically such antioxidants may do more harm than good.


Antioxidants  ROS RNS Oxidative stress Apoptosis Redox homeostasis 


  1. 1.
    El-Hossary GG, Hassan A, El-Shazly M, Ahmed ES, El-Gohary AA, Metwally FG, et al. Efficacy of alpha-lipoic acid against diabetes induced deterioration of blood antioxidants and diabetic retinopathy in experimental animals Aust. Aust J Basic Appl Sci. 2010;4:127–34.Google Scholar
  2. 2.
    Pazdro R, Burgess JR. The role of vitamin E and oxidative stress in diabetes complications. Mech. Ageing Dev. 2010;131:276–86.Google Scholar
  3. 3.
    Singh PP, Mahdi F, Roy A, Sharma S. Reactive oxygen species, reactive nitrogen species and antioxidants in etiopathogenesis of diabetes mellitus type 2. Ind J Clin Biochem. 2009;24:324–42.CrossRefGoogle Scholar
  4. 4.
    Singh PP, Sharma P. Antioxidant basket: do not mix apples and oranges. Ind J Clin Biochem. 2009;24:211–4.CrossRefGoogle Scholar
  5. 5.
    Singh PP, Gupta G, Barjatia MK, Adhikari D. Oxidants antioxidants dovetail hypothesis: let us not sprint before we stand. In: Singh PP et al., editors. Free radicals and antioxidants in health and disease: concordance and discordance. Chowdhary Offset Pvt. Ltd. Udaipur; 2007. p. 1–31.Google Scholar
  6. 6.
    Singh PP, Pendse AK, Bomb BS, Barjatiya MK, Ghosh R. Free radicals and antioxidant: sort out facts from fiction (Editorial). 1999. p. XV–XlX.Google Scholar
  7. 7.
    Singh PP, Gupta S. Antioxidants and cardiovascular system. In: Singh PP, et al., editors. Free radicals and antioxidants in health and disease: concordance and discordance. Udaipur: Chowdhary Offset Printer Pvt. Ltd.; 2007. p. 119–28.Google Scholar
  8. 8.
    Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Joshua T. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell. 2007;39:44–84.CrossRefGoogle Scholar
  9. 9.
    Sies H, Stahl W. Vitamins E and C, β-carotene and other carotenoids antioxidants. Am J Clin Nutr. 1995;62(suppl):1315S–21S.PubMedGoogle Scholar
  10. 10.
    Seifried HE, Anderson DE, Trisher EI, Milner JA. A review of interaction among dietary antioxidants and reactive oxygen species. J Nutr Biochem. 2007;18:567–79.PubMedCrossRefGoogle Scholar
  11. 11.
    Tewari AK. Antioxidants: new generation therapeutic base for treatment of polygenic disorders. Curr Sci. 2004;86:192–212.Google Scholar
  12. 12.
    Cadenas E, Packer L. Hand book of antioxidants. New York: Marcel Dekker Inc.; 2002.Google Scholar
  13. 13.
    Halliwell B. Food derived antioxidant: how to evaluate their importance in food and in vivo. In: Cadenas E, Packer L, editors. Handbook of antioxidants. New York: Marcel, Inc.; 2002. p. 1–45.Google Scholar
  14. 14.
    Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 3rd ed. New York: Oxford University Press; 1999.Google Scholar
  15. 15.
    Halliwell B. Antioxidants and human disease. Nutr Rev. 1997;55:S44–52.PubMedCrossRefGoogle Scholar
  16. 16.
    Halliwell B. Antioxidants and human disease. Am J Clin Nutr. 2005;82:1141–2.Google Scholar
  17. 17.
    Halliwell B. Drug antioxidant effects. Drugs. 1991;42:569–81.PubMedCrossRefGoogle Scholar
  18. 18.
    Gutteridge JMC, Halliwell B. Antioxidants in nutrition, health and disease. New York: Oxford University Press; 1996.Google Scholar
  19. 19.
    Pryor WA. Vitamin E and heart disease: basic science to clinical intervention trails. Free Radic Biol Med. 2000;28:141–64.PubMedCrossRefGoogle Scholar
  20. 20.
    Narsinga Rao BS. Nutrient requirement and safe dietary intake for Indians. NFI Bull (Bulletin of the Nutrition Foundation of India). 2010;31:1–5.Google Scholar
  21. 21.
    Loscalzo J. Membrane redox state and apoptosis death by peroxide. Cell Metab. 2008;8:182–3.PubMedCrossRefGoogle Scholar
  22. 22.
    Clarke MW, Burnett JR, Croft KD. Vitamin E in human health and disease. Crit Clin Lab Sci. 2008;45:417–50.CrossRefGoogle Scholar
  23. 23.
    Buettner GR. Commentary on: faster plasma disappearance in smokers is normalization by vitamin C supplementation. Free Radic Biol Med. 2006;40:1–4.CrossRefGoogle Scholar
  24. 24.
    Droge W. Free radicals in physiological control of cell function. Physiol Rev. 2002;82:47–95.PubMedGoogle Scholar
  25. 25.
    Dalle–Donne L, Rossi R, Colombo R, Giustarini D, Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem. 2006;52:601–23.PubMedCrossRefGoogle Scholar
  26. 26.
    Baxi M, Baxi J, Adhikari D, Singh PP. Clinicopathological profile of fibrocystic disease of breast with and without malignancy and assessment of efficacy of vitamin E supplementation in mastalgia due to fibrocystic disease: results from a tertiary care centre in western Nepal. 42nd World Congress of the Int. Soc. Surgery Montreal Canada. 2007; p. 148.Google Scholar
  27. 27.
    Brigelius-Flohe R, Traber GM. Vitamin E: function and metabolism. FASEB J. 1999;13:1145–55.PubMedGoogle Scholar
  28. 28.
    Murray RK, Bender DA, Bothan KM, Kennelly PJ, Rodwell VW, Weid PA. Harper’s illustrated biochemistry 28 in Ed. McGraw Hill. Lange. N.Y.P. p. 468–469.Google Scholar
  29. 29.
    Owusu-Ansah E, Banerjee U. Reactive oxygen species prime Drosophilla hemaetopoitic progenitors for differentiation. Nature. 2009;461:537–42.PubMedCrossRefGoogle Scholar
  30. 30.
    Azzi A, Aratri E, Boscoboinik D, Clement S, Ozer NK, Ricciarelli R, Spychers S. Molecular basis of alpha-tocopherol control of smooth muscle cell proliferation. Biofactors. 1998;7:3–14.PubMedCrossRefGoogle Scholar
  31. 31.
    Boscoboinik D, Szewczyk A, Hensey C, Azzi A. Inhibition of cell proliferation by alpha-tocopherol: role of protein kinase C. J Biol Chem. 1991;266:6181–94.Google Scholar
  32. 32.
    Beyer RE. The role of ascorbate in antioxidant protection of biomembranes: interaction with vitamin E and coenzyme Q. J Bioenerg Biomeds. 1994;26:349–57.CrossRefGoogle Scholar
  33. 33.
    Vasudevan DM, Sreekumari S, Vaidyanathan K. Text book of biochemistry for medical students. 6th ed. New Delhi: Jaypee Brothers Med Pub; 2011. p. 407–10.Google Scholar
  34. 34.
    Freedman JE, Farhat JH, Loscalzo J, Keanney JF Jr. Alpha-tocopherol inhibits aggregation of human platelets by a protein-Kinase-C-dependent mechanism. Circulation. 1996;94:2434–40.PubMedGoogle Scholar
  35. 35.
    Keaney JF Jr, Guo Y, Cunningham D, Shwaery GT, Xu A, Vita JA. Vascular micarporation of alpha-tocopherol prevents endothelial days function due to oxidized LDL by inhibiting protein kinase C stimulation. J Clin Invest. 1996;88:386–94.CrossRefGoogle Scholar
  36. 36.
    Tasinato A, Boscoboink D, Bartoli G, Maroni P, Azzi A. Alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentration, correlates with protein Kinase C inhibition and is independent of its antioxidant properties. Proc Natl Acad Sci USA. 1995;92:12190–4.PubMedCrossRefGoogle Scholar
  37. 37.
    Theopold U. A bad boy comes good. Nature. 2009;461:486–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Loh K, Derg H, Fukushina A, Cai X, Boivin B, Glalic G, et al. Reactive oxygen enhance insulin sensitivity. Cell Met. 2009;10:27–260.CrossRefGoogle Scholar
  39. 39.
    Mathewa J, Galarneu L, Loranger A, Gilbert S, Marceu N. Kertatin-protein Kinase interaction in reactive oxygen species-induced hepatic cell death through mitochondrial signaling. Free Radic Biol Med. 2008;45:413–24.CrossRefGoogle Scholar
  40. 40.
    Veal EA, Day AM, Morgan BA. Hydrogen sensing and signaling. Mol Cell. 2007;26:1–14.PubMedCrossRefGoogle Scholar
  41. 41.
    D’Autreaux B, Toledano M. ROS as signaling molecules: mechanisms that generate specificity in ROS homeostasis. Mol Cell Biol. 2007;8:813–24.Google Scholar
  42. 42.
    Seilar A, Schneider M, Forster H, Roth S, Wirth EK, Culmsee C, et al. Glutathione peroxidase 4 senses and translates oxidative stress into 12/16-lipoxygenase dependent and AIF mediated cell death. Cell Met. 2008;8:237–48.CrossRefGoogle Scholar
  43. 43.
    Juranek L, Bezek S. Controversy of free radical hypothesis reactive oxygen species hypothesis cause of consequence of tissue injury? Gen Physiol Biophys. 2005;24:263–78.PubMedGoogle Scholar
  44. 44.
    Poli G, Leonarduzzi G, Biasi F, Chairpotto E. Oxidative stress and cell signaling. Curr Med Chem. 2004;11:1163–82.PubMedGoogle Scholar
  45. 45.
    Thannickal VJ, Fanburg Bl. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol. 2000;279:L 1005–28.Google Scholar
  46. 46.
    Brooks PS, Yoon Y, Robothan JL, Andres MW, Sheu SS. Calcium, ATP and ROS: a mitochondrial love hate triangle. Am J Phys. 2004;287:c817–23.CrossRefGoogle Scholar
  47. 47.
    Mehta G, Kotharie S, Singh PP. Breast cancer in developing population a nutrition caveat. Ind J Clin Biochem. 2001;16:65–71.CrossRefGoogle Scholar
  48. 48.
    Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective or an old paradigm. Diabetes. 1999;48:1–9.PubMedCrossRefGoogle Scholar
  49. 49.
    Risal S, Adhikari D, Alurkar VM, Singh PP. Oxidative stress and antioxidant status in Cardiovascular diseases in population of western Nepal. Kathmandu Univ Med J. 2006;4:270–4.Google Scholar
  50. 50.
    Maharajan BR, Jha JC, Vishwanath P, Alurkar M, Singh PP. Oxidant and antioxidant status and lipid profile in hypertension patients. J Nepal Health Res Comc. 2008;6:63–8.Google Scholar
  51. 51.
    Singh PP, Mahdi F. Free radical and antioxidant covenant in etiopathogenesis of diabetes mellitus. International Conference on Advances in Free Radical Research; Natural Products Antioxidants Protectors & 8th Ann. Meeting of Society Free Radical Research in India. Lucknow Abstract, 2009; p. 8.Google Scholar
  52. 52.
    Nathan C. Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling. J Clin Invest. 2003;111:769–78.PubMedGoogle Scholar
  53. 53.
    Gulshan K, Rovinsky SA, Coleman ST, Moye-Rowley WS. Oxidant specific folding of Yap 1-p regulates both transcriptional activation and nuclear localization. J Biol Chem. 2005;280:40524–33.PubMedCrossRefGoogle Scholar
  54. 54.
    Dotan Y, Pinchuk I, Litchenberg D, Leshno M. Decision analysis supports the paradigm that indiscriminate supplementation of vitamin E does more harm than good. Arterioscle Thromb Vasc Biol. 2009;29:1304–9.CrossRefGoogle Scholar
  55. 55.
    Bielakovic G, Nikolova D, Simonetti RG, Gludd C. Antioxidant supplements for preventing cancers. USA: The Cochrane Collaboration John Wiley & Sons Ltd.; 2008. p. 1–79.Google Scholar
  56. 56.
    Bjalakovic G, Nikolova D, Gludd LL, Smonetti RG, Gludd C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA. 2007;297:842–57.CrossRefGoogle Scholar
  57. 57.
    Bejelakovic G, Nikolova D, Simonetti RG, Gludd C. Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta analysis. Lancet. 2004;364:1219–28.CrossRefGoogle Scholar
  58. 58.
    Marchivdi R, Levantesi G, Macchia A, Marfisi RM, Nicolosi GL, Tavazzi L, et al. Vitamin E increases the risk of increasing heart failure after myocardial infraction: results from the GISSI Preventive Trial. J Cardiovasc Med (Hagesgerstown). 2006;6:347–50.CrossRefGoogle Scholar
  59. 59.
    Daga MK, Mohan A. Antioxidants and disease–current status. Assoc Phys Ind. 1996;44:703–14.Google Scholar
  60. 60.
    Buettner GR. Commentry on: faster plasma vitamin E disappearance in smokers is normalized by vitamin C supplementation. Free Radic Biol Med. 2006;40:1–3.CrossRefGoogle Scholar
  61. 61.
    Mehta G, Singh PP. Breast cancer scenario in north- west India with special reference to oxidant antioxidant juxtaposition. In: Singh PP, et al., editors. Free radical and antioxidants in health and disease: concordance and discordance. Udaipur: Chowdhary Offset Printers; 2007. p. 94–112.Google Scholar
  62. 62.
    Valko M, Rhodes CJ, Marcol Izakonic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress induced cancer. Chem Biol Interact. 2006;160:1–40.PubMedCrossRefGoogle Scholar
  63. 63.
    Slorz P. Reactive oxygen species in tumor progression. Front Biosci. 2005;10:1881–6.CrossRefGoogle Scholar
  64. 64.
    Adhikari D, Baxi J, Risal S, Singh PP. Oxidative stress and antioxidant status in cancer patients and healthy subject: a case controlled study. Nepal Med J. 2005;7:112–5.Google Scholar
  65. 65.
    Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem. 2004;266:37–56.PubMedCrossRefGoogle Scholar
  66. 66.
    Serrano M, Blasco MA. Cancer and aging: convergent and divergent mechanisms. Nature. 2007;8:715–22.Google Scholar
  67. 67.
    Krishnaswamy K, Polasa K. Diet, nutrition and cancer-the Indian scenario. J Med Res. 1995;102:200–9.Google Scholar
  68. 68.
    Maharjan BR, Jha JC, Adhikari D, Akila Risal S, Singh PP, et al. Oxidant stress antioxidant status and lipid profile in ischemic heart disease patients from western Nepal. Nepal Med J. 2008;10:20–4.Google Scholar
  69. 69.
    Serdar Z, Aslan K, Dirican M, Sarandol E, Yesilbursa D, Serdar A. Lipid and protein oxidation and antioxidant status in patients with angiographically proven coronary artery disease. Clin Biochem. 2006;48:1–11.Google Scholar
  70. 70.
    Bachorun T, Soobrattee MA, Luximom- Ramma V, Aruoma OI. Free radicals and antioxidants in cardiovascular health and disease. IJMU. 2006;11:1–21.Google Scholar
  71. 71.
    Heistad DD. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol. 2006;26:689–95.PubMedCrossRefGoogle Scholar
  72. 72.
    Le Anh N. Hyperlipidemia and cardiovascular disease: oxidative damage and atherosclerosis. Curr Opin Lipidol. 2006;17:92–4.Google Scholar
  73. 73.
    Burrel CJ, Blake DR. Reactive oxygen metabolites and the human myocardium. Br Heart J. 1989;61:4–8.CrossRefGoogle Scholar
  74. 74.
    Curtis LK. Reversing atherosclerosis? New Eng J Med. 2009;360:1144–6.CrossRefGoogle Scholar
  75. 75.
    Schleicher E, Friess U. Oxidative stress, AGE, and atherosclerosis. Kid Int. 2007;72:S.17–26.CrossRefGoogle Scholar
  76. 76.
    Devaraj S, Tang R, Adams-Huet B, Harris A, Sreenivasan T, de-Lemos JA. Effects of high dose alpha-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary atery disease. Am J Clin Nutr. 2007;86:1392–8.PubMedGoogle Scholar
  77. 77.
    Stocker R, Kenny JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev. 2003;35:117–32.Google Scholar
  78. 78.
    Li D, Mehta JL. Oxidized LDL, a critical factor in atherogenesis. Cardiovas Res 2005;68:353–4.Google Scholar
  79. 79.
    Mueller CFH, Laude K, McNally JS, Harrison DG. Redox mechanisms in blood vessels. Arterioscler Thromb Vasc Biol. 2005;25:274–8.PubMedCrossRefGoogle Scholar
  80. 80.
    Jialal I, Devraj S. Antioxidant and atherosclerosis. Don’t throw out the baby with bath water. Circulation. 2003;107:926–8.PubMedCrossRefGoogle Scholar
  81. 81.
    Ross R. Atherosclerosis: an inflammatory disease. New Engl J Med. 1999;340:115–26.PubMedCrossRefGoogle Scholar
  82. 82.
    Resende R, Moreira PI, Proenca T, Deshpande A, Bnsciglio S, Pereira C, et al. Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease. Free Radic Biol Med. 2008;44:2051–7.PubMedCrossRefGoogle Scholar
  83. 83.
    Tanagno E, Bardini P, Guglielmotto M, Danni O, Tabaton M. The various aggregation states of beta-amyloid 1-42 mediate different effects on oxidative stress, neurodegeneration and BACE-1-expression. Free Radic Biol Med. 2006;41:202–12.CrossRefGoogle Scholar
  84. 84.
    Tretter L, Sips L, Adam-vizzi I. Initiation of neuronal damage by complex I deficiency and oxidative stress in Parkinson’s disease. Neurochem Res. 2004;29:569–77.PubMedCrossRefGoogle Scholar
  85. 85.
    Jenner P. Oxidative stress in Parkinson’s disease. Ann Neurol. 2003;53:S26–36.PubMedCrossRefGoogle Scholar
  86. 86.
    Butterfield DA, Castegra A, Lauderback CM, Drake J. Evidence that amyloid beta- peptide induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death. Neurotriol Aging. 2002;23:655–64.CrossRefGoogle Scholar
  87. 87.
    Montesa MJP, Rico MAG, Salguero MAS, Maicas IT, Munoz MCT, Tormo GS, et al. Study of oxidative stress in advanced kidney disease. Nefrologica. 2009;29:464–73.Google Scholar
  88. 88.
    Sathyapriya K, Vijayachandrika V, Paxameswari CS. Antioxidant status in polycystic end stage renal renal diseased patients and antihemolytic effect of Boerhaavia diffusa. Ind J Biochem Biophys. 2009;46:272.Google Scholar
  89. 89.
    Barjatiya MK, Nagamma T, Ahmed S, Mathur M, Singh PP. Status and intradialytic changes in reactive oxygen species activity and total antioxidants strength in chronic renal failure patients from India and Nepal. In: Singh PP, et al., editors. Free radicals and antioxidants in health and diseases: concordance and discordance. Udaipur: Chowdhary Offset Print; 2007. p. 238–45.Google Scholar
  90. 90.
    Diez BG. Progression of chronic renal failure and oxidative stress. Elect J Biomed. 2003;1:5–11.Google Scholar
  91. 91.
    Singh R, Singh S, Tripathi AK, Singh RK. Circadian periodicity of human circulating lipid peroxide and antioxidant enzymes as putative markers in cirrhosis of liver. In: Singh PP, editor. Free radic antioxidants: sort out facts from fiction. Udaipur: Chowdhary Offset Print; 1999. p. 223–37.Google Scholar
  92. 92.
    Fecher J, Lengyel G, Blazovics A, Hegedus E. Antioxidants therapy in liver disease. In: Singh PP, et al., editors. Free radic antioxidants. Sort out facts from fiction. Udaipur: Chowdhary Offset Print; 1999. p. 168–75.Google Scholar
  93. 93.
    Feher J, Cosmos G, Vereckel A. Role of free radicals in liver disease. In: Cosmos G, Feher J, editors. Free radical and the liver. Berlin: Springer Verlag; 1992. p. 1–12.Google Scholar
  94. 94.
    Paravicini TM, Touyz RN. NADPH oxidases, reactive oxygen species and hypertension: clinical implicators and therapeutic possibilities. Diab Care. 2008;31:S70–180.CrossRefGoogle Scholar
  95. 95.
    Sowers JR. Hypertension, angiotensin II and oxidative stress. New Eng J Med. 2002;346:1999–2001.PubMedCrossRefGoogle Scholar
  96. 96.
    Maurice MM, Nakamura H, Vander Voort EAM, Van Vliet A, Staal FJ, T, Tak PP et al. An altered redox state in hyporesponsiveness of synovial T cells in rheumatoid arthritis. J Immunol. 1997;158;1458–65.Google Scholar
  97. 97.
    Cunnane G, Fitz Gerald O, Beeton C, Cawston TE, Bresnihan B. Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis. Arth Rheumat. 2001;44:2263–74.CrossRefGoogle Scholar
  98. 98.
    Bauerova K, Bezek S. Role of reactive oxygen and nitrogen species in etiopathogenesis of rheumatoid arthritis. Gen Physiol Biophys. 1999;18:15–20.PubMedGoogle Scholar
  99. 99.
    Firestein GS, Echeverri F, Yeo M, Zvaifler NJ, Geren DR. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthiritis synovium. Proc Natl Acad Sci USA. 1997;94:10895–900.PubMedCrossRefGoogle Scholar
  100. 100.
    Alvardo C, Alvarez P, Puerto M, Gauwsseres N, Jinenez L, la Fuente MDe. Dietary supplementation with antioxidants improve functions and decreases oxidative stress of leukocytes from prematurely aging mice. Nutrition. 2006;22:767–77.CrossRefGoogle Scholar
  101. 101.
    Finkel T, Holbrook J. Oxidants, oxidative stress and the biology of aging. Nature. 2000;9:239–46.CrossRefGoogle Scholar
  102. 102.
    Ghosh R, Mehta A, Ramavatram DVVS, Barjatia MK, Singh PP. Pro oxidant antioxidant balance in aging. In: Singh PP, et al., editors. Free radical and antioxidants. Sort out facts from fiction. Udaipur: Chowdhary Offset Print; 1999. p. 127–37.Google Scholar
  103. 103.
    Beckman KB, Ames BN. Free radical theory of aging natures. Phys Rev. 1998;78:547–81.Google Scholar
  104. 104.
    Freanzini L, Ardigo D, Zavaroni I. Dietary antioxidant and glucose metabolism. Curr Opin Clin Nutr Met Care. 2008;11:471–6.CrossRefGoogle Scholar
  105. 105.
    Mootha UK, Lindgren CM, Errikson KF, Subramanian A, Sihag S, Lehar J, et al. PGC-1 alpha-responsive genes involved in oxidative phosphorylation are coordinately down regulated in human diabetes. Nat Genet. 2003;34:267–73.PubMedCrossRefGoogle Scholar
  106. 106.
    Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes. 2003;52:1–8.PubMedCrossRefGoogle Scholar
  107. 107.
    Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endo Rev. 2002;23:599–622.CrossRefGoogle Scholar
  108. 108.
    Goh SY, Cooper ME. The role of advanced glycation end products in progression and complication of diabetes. J Clin Erdocrinol Metab. 2008;93:1143–52.CrossRefGoogle Scholar
  109. 109.
    Aruoma OI, Neergheen VS, Bahourn T, Jen L. Free radicals, antioxidants and diabetes mellitus: embryopathy, retinopathy, neuropathy, nephropathy and cardiovascular complications. Neuroembryol Aging. 2006/2007; 4:117–37.Google Scholar
  110. 110.
    Gratt GM, Schoutern EG, Kok FJ. Effect of daily vitamin E and multivitamin supplementation on acute respiratory tract infection in elderly persons: a randomized controlled trial. JAMA. 2002;288:715–21.CrossRefGoogle Scholar
  111. 111.
    Hemila H, Virtamo J, Albances D, Kaprio J. Vitamin E and beta carotene supplementation and hospital treated pneumonia incidence in male smokers. Chest. 2004;125:537–65.CrossRefGoogle Scholar
  112. 112.
    Singh PP, Kothari S, Bhasin S, Bhargav U. Diminished endogenous antioxidant defence in the etiology of senile cataract formation. SFRR-India Bull. 2004;3:11–4.Google Scholar
  113. 113.
    Babizhayev MA. Failure to withstand oxidative stress induced by phospholipids hydroperoxides as a possible cause of the lens opacities in systemic diseases and aging. Biochem Biophys Acta. 1996;1315(2):87.PubMedGoogle Scholar
  114. 114.
    Tinahone FJ, Murri-Pierri M, Garrido-Sanchez L, Garca-Almeida JM, Garcia-Serrano S, Garcia-Ames J, Garcia-Fuentes E. Oxidative stress in severely obese person is greater in those with insulin resistance. Obesity. 2009;17:240–6.Google Scholar
  115. 115.
    Katakan PV, Domoki F, Snipes JA, Busija AR, Jarajapu YP, Bushija DW. Impaired mitochondria dependent vasodilation in cerebral arteries of Zucker obese rats with insulin resistance. Am J Physiol Regul Integr Comp Physiol. 2009;296:R289–98.Google Scholar
  116. 116.
    Nathan C. Epidemic inflammations: Pondoring obesity. Molecular Med. 2009;14:485–92.Google Scholar
  117. 117.
    Wells GD, Noseworthing MD, Hamilton J, Tarnopolska M, Teir I. Skeletal muscle metabolic dysfunction in obesity and metabolic syndrome. Can J News Sci. 2008;35:31–40.Google Scholar
  118. 118.
    Farooqui IS, O’Rahilly S. Genetics of obesity in humans. End Rev. 2006;27:710–8.Google Scholar
  119. 119.
    Foster-Schubert KE, Cummings DE. Emerging therapeutic strategies for obesity. Endo Rev. 2006;27:779–93.Google Scholar
  120. 120.
    Buonocore G, Groenendaal F. Antioxidant strategies. Sem Fetal Neonat Med. 2008;12:287–95.CrossRefGoogle Scholar
  121. 121.
    Smith AR, Shenvi SV, Lipoice Widlansky M, Suh JH, Hgen TM. Lipoic acid as a potential therapy for chronic disease associated with oxidative stress. Curr Med Chem. 2004;11:1135–46.PubMedGoogle Scholar
  122. 122.
    Lynd DD, Gunnet CA, Chu Y, Brooks RM, Faraci FM, Heistad DD. Gene transfer of extra cellular superoxide dismutase improves relaxation of aorta after treatment with endotoxin. Am J Physiol Heart Circ Physiol. 2004;56:H805–11.CrossRefGoogle Scholar
  123. 123.
    Cleveland JL, Kastan MB. A radical approach to treatment. Nature. 2000;407:309–11.PubMedCrossRefGoogle Scholar
  124. 124.
    Maxwell SRJ. Prospects for the use of antioxidant therapies. Drugs. 1995;49:345–61.PubMedCrossRefGoogle Scholar
  125. 125.
    Blunberg JB. Considerations of scientific substantiation for antioxidant vitamins and beta-carotene in disease prevention. Am J Clin Nutr. 1995;62(suppl):1521S–6S.Google Scholar
  126. 126.
    Rice-Evans CA, Diplock AT. Current status of antioxidant therapy. Free Radic Biol Med. 1993;15:77–96.PubMedCrossRefGoogle Scholar
  127. 127.
    Downey J, Onar B, Ooiwa H, Mc Cord J. Superoxide dismutase therapy for myocardial ischemia. Free Radic Res Commun. 1991;703:12–3.Google Scholar
  128. 128.
    Pocobelli G, Peters U, Peters U, Kristal AR, White E. Use of supplements of multivitamins, vitamin C and vitamin E in relation to mortality. Am J Epidemiol. 2009;170:472–83.PubMedCrossRefGoogle Scholar
  129. 129.
    Miller ER, Pastor –Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high dosage vitamin E supplementation may increase all cause mortality. Ann Intern Med. 2005;142:37–46.PubMedGoogle Scholar
  130. 130.
    Blomhoff R. Dietary antioxidants and cardiovascular disease. Curr Opin Lipidol. 2005;16:47–54.PubMedCrossRefGoogle Scholar
  131. 131.
    Lichtenstein AH. Nutrient and cardiovascular disease no easy answers. Curr Opin Lipidol. 2005;16:1–3.PubMedCrossRefGoogle Scholar
  132. 132.
    Johansen JS, Harris AK, Rychly DJ, Ergul A. Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc Diabetol. 2005;4:1–11.CrossRefGoogle Scholar
  133. 133.
    Williams KJ, Fisher EA. Oxidation, lipoproteins and atherosclerosis: which is wrong, the antioxidants or theory? Curr Opin Clin Nutr Care. 2005;8:139–46.CrossRefGoogle Scholar
  134. 134.
    Singh S, Farzana M, Singh PP. Insinuating role of free radicals and placating behaviour of antioxidant in diabetes mellitus. J Physiol. 2009;3:5–8.Google Scholar
  135. 135.
    Sokol RJ. Vitamin E toxicity. Pediatrics. 1984;74:564–5.PubMedGoogle Scholar
  136. 136.
    Bensuasson RV, Land EJ, Truscott TG. Excited states and free radicals in biology and medicine: contribution from flash photolysis and PulseRadiolysis. New York: Oxford University Press; 1993. p. 101–41.Google Scholar
  137. 137.
    Gerschman R, Gilbert DL, Nye SW, Dwyer P, Dwyer P, Fenn WO. Oxygen poisoning and X-irradiation, A mechanism in common. Science. 1954;119:623–6.PubMedCrossRefGoogle Scholar
  138. 138.
    Harman D. Aging; a theory based on free radical and radiation chemistry. J Gerontol. 1956;2:298–300.Google Scholar
  139. 139.
    Harman D. Free radical theory of aging. In: Johnson JE Jr, et al., editors. Free radicals, aging and degenerative disease. NY. 1982. p. 3–49.Google Scholar
  140. 140.
    de Magalhes JP ole, Church GM. Cell discover fire: employing reactive oxygen species in development and consequences for aging. Exp Gerontol. 2005;41:1–10.CrossRefGoogle Scholar
  141. 141.
    Bujisse B, Feskens EJM, Schlettwein-Gsell D, Ferry M, Kok FJ, Kromhout D, et al. Plasma carotene and alpha-tocopherol in relation to 10 yr all-cause and cause-specific mortality in European elderly: the survey in Europe on Nutrition and the Elderly, a Concerted Action (SENECA). Am J Clin Nutr. 2005;82:879–86.Google Scholar
  142. 142.
    Lin J, Cook NR, Albert C, Zaharris E, Gaziano JM, Denberg MV. Vitamin C and E and beta carotene supplementation and cancer risk: a randomized controlled trial. J Natl Cancer Inst. 2009;10:14–23.Google Scholar
  143. 143.
    Sen CK. Oxidants and antioxidants in exercise. J Appl Physiol. 1995;79:675–86.PubMedGoogle Scholar
  144. 144.
    Halliwell B, Whitemam M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Brit J Pharmacol. 2004;142:231–55.CrossRefGoogle Scholar
  145. 145.
    Araki E, Nishikawa N. Oxidative stress: a cause and therapeutic target of diabetic complications. J Diab Invest. 2010;1:90–6.CrossRefGoogle Scholar
  146. 146.
    Houstis N, Rosen ED, Lander ES. Reactive oxygen species have causal role in multiple forms of insulin resistance. Nature. 2006;440:944–8.PubMedCrossRefGoogle Scholar
  147. 147.
    Fridovich I. Superoxide radical and superoxide dismutase. Ann Red Biochem. 1995;64:97–112.CrossRefGoogle Scholar
  148. 148.
    Mc Cord JM, Fridovich I. Superoxide dismutase. An enzyme function for erythrocuprin. J Biol Chem. 1969;224:6049–55.Google Scholar
  149. 149.
    Hathock JN, Azzi A, Blumberg J, Bray T, Dickinson A, Frei B, et al. Vitamins E and C are safe across a broad range of intakes. Am J Clin Nutr. 2005;81:736–45.Google Scholar
  150. 150.
    Sies H, Krinsky NI. The present status of antioxidant vitamins and beta-carotene. Am J Clin Nutr. 1995;62(suppl):1299-S–300-S.Google Scholar
  151. 151.
    Diplock AT. Antioxidant nutrients and disease prevention: an overview. Am J Clin Nutr. 1991;53:S189–93.Google Scholar
  152. 152.
    Potter JD. Vegetable, fruits and cancer. Lancet. 2005;366:527–30.PubMedCrossRefGoogle Scholar
  153. 153.
    Cao G, Both SL, Sadowski JA, Prior RL. Increases in human plasma antioxidant capacity after consumption of controlled diets high in fruits and vegetables. Am J Clin Nutr. 1998;68:1081–7.PubMedGoogle Scholar
  154. 154.
    Serafini M, Bellocco R, Wolk A, Ekstram AM. Total antioxidant potential of fruits and vegetables and risk of gastric cancer. Gastroenterology. 2002;123:985–91.PubMedCrossRefGoogle Scholar
  155. 155.
    Genkinger JM, Platz EA, Hoffman SC, Comstock GW, Helzlsourer KJ. Fruit vegetable and antioxidant intake and all cause cancers and cardiovascular disease mortality in a community dwelling population in Washington country Maryland. Am J Epidemiol. 2004;160:1223–33.PubMedGoogle Scholar
  156. 156.
    Kelemen LE, Cohan JR, Lim U, Davis S, Cozen W, Schank M, et al. Vegetables, fruits and antioxidant related nutrients and risk of non-Hodghkin lymphoma: a National cancer Institute-Surveillance epidemiology and results population-based case control study. Am J Clin Nutr. 2006;83:1401–10.PubMedGoogle Scholar
  157. 157.
    Lock K, Pomerleau J, Causer L, Altman DR, Mckee M. The global burden of disease attributable to low consumption of fruits and vegetables: implications for global strategy an diet. Bull. W.H.O. 2005;83:100–8.PubMedGoogle Scholar
  158. 158.
    Szeeto Y-T, Benzie IFF. Effects of dietary antioxidants and human DNA ex vivo. Free Radic Biol Res. 2002;36:113–8.CrossRefGoogle Scholar
  159. 159.
    Perrig WJ, Perrig P, Stahelin HB. The influence of antioxidants on cognitive decline in the elderly. In: Basu TK, et al., editors. Antioxidants in human health.  Willingford, Oxon, Uk: CAB International; 1999. p. 335–49.Google Scholar
  160. 160.
    Frei B, Forte TM, Ames BN, Cross CE. Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Biochem J. 1991;247:133–8.Google Scholar
  161. 161.
    Reznick AZ, Cross CE, Hu M, Suzuki YJ, Khwaja S, Safadi A, et al. Modification of plasma proteins by cigarette smoke as measured by protein carbonyl. Biochem J. 1992;286:607–11.PubMedGoogle Scholar
  162. 162.
    Young JF, Nielsen SE, Haraldsdottir J. Effect of fruit juice on urinary querchetin excretion and biomarkers of oxidative stress. Am J Clin Nutr. 1999;69:87–94.PubMedGoogle Scholar
  163. 163.
    Buttner GR. The pecking orders of free radicals and antioxidants: lipid peroxidation, alpha tocopherol and ascorbate. Arch Biochem Biophys. 1993;300:535–43.CrossRefGoogle Scholar
  164. 164.
    Padyatty SJ, Daruwala R, Wang Y, Eck PK, Song J, Koh WS, et al. Vitamin C: from molecular actions to optimum intake. In: Cadenas E, Packer L, et al., editors. Handbook of antioxidants. New York, USA: Marcel Dekker Inc.; 2002. p. 117–45.Google Scholar
  165. 165.
    Creagan ET, Moertel CG, O’ Fallon JR. Failure of high dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. New Eng J Med. 1979;301:687–90.PubMedCrossRefGoogle Scholar
  166. 166.
    Moertei CG, Flemming TR, Creagon ET, et al. High dose vitamin C verses placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. New Eng J Med. 1985;312:137–41.CrossRefGoogle Scholar
  167. 167.
    Pendse AK, Purohit AK, Ghosh R, Goyal A, Singh PP. The effect of ingestion of mega doses of ascorbic acid on urinary oxalate excretion in normal subjects and store formers. In: Schwille PO, et al., editors. Urolithiaisis and related clinical research. NewYork, USA: Plenum Press; 1984. p. 225–8.Google Scholar
  168. 168.
    Singh PP, Mehta A, Rao GS, Pendse AK, Barjatiya MK, Ramavataram DVSS. Antioxidant status peroxidative stress and urinary excretion of calcium and oxalate in kidney diseases with special reference to urolithiasis. In. Pak CYC, et al., editors. Urolithiasis-96. Dallas, USA: The Printer Inc., p. 26–28.Google Scholar
  169. 169.
    Singh PP, Rajbala, Ramavataram DVSS, Pendse AK, Barjatia MK. Extended experimental studies to evaluate the role of ascorbic acid in lithogenesis under different set of conditions. In: Pak CYC, et al., editors. Urolithiasis. Dallas, USA: Millet the Printer Inc.; 1996. p. 349–50.Google Scholar
  170. 170.
    Singh PP, Sharma DC, Rathore V, Surana SS. An investigation into the role of ascorbic acid in renal calculosis in albino rats. J Urol. 1988;139:156–7.PubMedGoogle Scholar
  171. 171.
    Aw TY, Wierzbicka G, Jones DP. Oral glutathione increases tissue glutathione in vivo chem. Biol Interact. 1991;80:89–97.CrossRefGoogle Scholar
  172. 172.
    Tirosh O, Roy S, Packer L. Lipoic acid, cellular metabolism, antioxidant activity and clinical relevance. In: Cadenas E, Packer L, editors. Hand book of antioxidants. 2nd ed. New York: Marcel Dekker Inc.; 2002. p. 473–87.Google Scholar
  173. 173.
    Moreau R, Znang W, Hgen TM. Cellular effects of lipoic acid and its role in aging. In: Cadenas E, Packer L, editors. Handbook of antioxidants. 2nd ed. New York: Marcel Dekker Inc.; 2002. p. 489–510.Google Scholar
  174. 174.
    Jones DP. Bioavailability of glutathione. In: Cadenas E, Packer L, editors. Handbook of antioxidants. New York: Marcel Dekker Inc.; 2002. p. 549–64.Google Scholar
  175. 175.
    Jones DP, Coates RJ, Flagg EW, Eley JW, Block G, Greenberg RS, et al. Glutathione in food listed in National Cancer Institute Health Habits and History Food Frequency Questionnaire. Nutr Cancer. 1992;17:57–75.PubMedCrossRefGoogle Scholar
  176. 176.
    Flagg EW, Coates RJ, Jone DP, Byers TE, Green berg RS, Gridley G, et al. Dietary glutathione intake and risk of oral and pharangeal cancer. Am J Epidemiol. 1994;139:453–65.PubMedGoogle Scholar
  177. 177.
    Panpilla A, Visviki A, Paolicchi A, DeTata V, Casini AF. The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol. 2003;66:1499–503.CrossRefGoogle Scholar
  178. 178.
    Livingstone C, Davis J. Targeting therapeutics against glutathione depletion in diabetes and its complications. Brit J Diab Vas Dis. 2007;7:258–65.CrossRefGoogle Scholar
  179. 179.
    Johnston CS, Meyer CG, Srilakshmi JC. Vitamin C elevates red blood cell glutathione in healthy adults. Am J Clin Nutr. 1993;140:3–5.Google Scholar
  180. 180.
    Deneka SM, Fanburg BL. Regulation of cellular glutathione. Am J Physiol Lung Cell Mol Physiol. 1989;257:E790–800.Google Scholar
  181. 181.
    Meister A. Glutathione metabolisms and its selective modification. J Biol Chem. 1988;263:17205–8.PubMedGoogle Scholar
  182. 182.
    Cay M, Naziroglu M, Koylu H. Selenium and vitamin E modulate cigarette smoke exposure-induced oxidative stress in blood of rats. Biol Trace Elem Res. 2009;131:62–70.PubMedCrossRefGoogle Scholar
  183. 183.
    Burtis CA, Ashwood ER, Bruns DE. Tietz text book of clinical chemistry and molecular diagnosis. 4th ed. St Louis, USA: Saunders; 2006.Google Scholar
  184. 184.
    Jellifee DB. The Assessment of the Nutritional Status of the Community. WHO Monograph Series No. 53.Google Scholar
  185. 185.
    Gey KF. Vitamin E plus C and interacting coutrients required for optional health. A critical and constructive review of epidemiology and supplementation data regarding cardiovascular diseases and cancer. Biofactors. 1998;7:113–74.PubMedCrossRefGoogle Scholar
  186. 186.
    Gey KF, Moser UK, Jordon P, Stahelin HB, Eichholzor M, Ludin E. Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention with carotene and vitamins. Am J Clin Nutr. 1993;57(Supp):787 S–99 S.Google Scholar
  187. 187.
    Lonn E, Bosch J, Yusuf S, et al. Effects of long term supplementation on cardiovascular events and cancer a randomized controlled trial. JAMA. 2005;293:1338–47.PubMedCrossRefGoogle Scholar
  188. 188.
    Adam BD, Adams WW. Antioxidants in photosynthesis and human nutrition. Science. 2002;298:2149–53.CrossRefGoogle Scholar
  189. 189.
    Wang XD, Liu C, Bronson RT, et al. Retinoid signaling and activator protein 1 expression in ferrets given beta carotene supplements and exposed to tobacco smoke. J Natl Cancer Inst. 1999;91:60–6.PubMedCrossRefGoogle Scholar
  190. 190.
    Lee SH, Oe T, Blair IA. Vitamin C induced decomposition of lipid hydroperoxide to endogenous genotoxins. Science. 2001;292:2083–6.PubMedCrossRefGoogle Scholar
  191. 191.
    Mustacih DJ, Leonard SW, Devereaux MW, Sokol RJ, Traber MG. Alpha-tocopherol regulation of hepatic cytochrome. P-450 and ABC transporters in rats. Free Radic Biol Med. 2006;41:1069–78.CrossRefGoogle Scholar
  192. 192.
    Brigelius-Flohe R. Induction of drug metabolism enzymes by vitamin E. J Plant Physiol. 2005;162:797–802.PubMedCrossRefGoogle Scholar
  193. 193.
    Landes N, Pfuluger P, Kluth D, Birringer M, Rahur R, Bol GF, et al. Vitamin E activates gene expression via the pregnane X receptor. Biochem Pharmacol. 2003;65:269–73.PubMedCrossRefGoogle Scholar
  194. 194.
    Finendegen LE. Reactive oxygen species in cell responses to toxic agents. Hum Exp Toxicol. 2002;21:85–90.CrossRefGoogle Scholar
  195. 195.
    Ravati A, Ahlemayer B, Becker A, Krrieglstein J. Preconditioning-induced neuroprotection is mediated by reactive oxygen species. Brain Res. 2002;866:23–32.CrossRefGoogle Scholar
  196. 196.
    ATBC Study (Alpha-Tocopherol, Beta-carotene Cancer Prevention Study). Incidence of cancer and mortality following ά-tocopherol and β-carotene supplementation. JAMA. 2003;290:476–85.CrossRefGoogle Scholar
  197. 197.
    Northrop-Clewes CA, Thurnhan N. Monitoring micronutrients in cigarette smokers. Clin Chim Acta. 2007;377:14–38.PubMedCrossRefGoogle Scholar
  198. 198.
    Hennekens CH, Buring JE, Mason JE, Stamper M, Rosner B, Cook NR, et al. Lack of long term supplementation with beta-carotene on the incidence of malignant neoplasma and cardiovascular disease. New Eng J Med. 1996;334:1145–55.PubMedCrossRefGoogle Scholar
  199. 199.
    Goodman GE, Thornquist MD, Balmes J, Cullen MR, Meyskens FL Jr, Omenn GS, Valanis B, Williams JH Jr. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. J Natl Cancer Inst. 2004;96(23):1743–50.PubMedCrossRefGoogle Scholar
  200. 200.
    Rodrigo R, Prat H, Prassalacqua W, Aryas J, Bachler JP. Decrease in oxidative stress through supplementation of vitamins C and E is associated with a reduction of blood pressure in patients with essential hypertension. Clin Sci. 2008;114:625–34.PubMedCrossRefGoogle Scholar
  201. 201.
    Kappus H, Diplock AT. Tolerance and safety of E up to 3200 I.V/day vitamin E: a toxicological position report. Free Rad Biol Res 1992;13:55–74.CrossRefGoogle Scholar
  202. 202.
    Traber MG. How much vitamin E? Just enough. Am J Clin Nutr. 2006;84:959–60.PubMedGoogle Scholar
  203. 203.
    Lawlor DA. Those confounded vitamins: what can we learn from differences between observational versus randomized trial evidence. Lancet. 2004;363:1724–7.PubMedCrossRefGoogle Scholar
  204. 204.
    Heart Outcomes Prevention Evaluation study Investigators. Vitamin E supplementation and cardiovascular events in high risk patients. New Eng J Med. 2000;342:154–60.CrossRefGoogle Scholar
  205. 205.
    Loan E, Yusuf S, Dzavik V. Effcets of rampril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with rampril and vitamin E (SECURE Trial). Circulation. 2001;103:919–25.Google Scholar
  206. 206.
    De Gaetano G. Collaborative Group of Primary Prevention Project Low dose aspirin and vitamin E in people with cardiovascular risk: a randomized trial in general practice. Lancet. 2001;357:89–95.PubMedCrossRefGoogle Scholar
  207. 207.
    Boaz M, Smetana S, Wemistein T. Secondary prevention with antioxidants of cardiovascular disease in end stage renal disease (SPACE Trial): randomized placebo controlled trial. Lancet. 2000;356:1213–8.PubMedCrossRefGoogle Scholar
  208. 208.
    Gaede P, Vedel P, Larsen N, Jensen GVH, Parving HH, Pederson O. Multifunctional intervention and cardiovascular disease in patients with type 2 diabetes. New Engl J Med. 2003;348:383–93.PubMedCrossRefGoogle Scholar
  209. 209.
    Harvard Health Letter. Taking stock of antioxidants. 2003;27(4):283–4.Google Scholar

Copyright information

© Association of Clinical Biochemists of India 2010

Authors and Affiliations

  • P. P. Singh
    • 1
  • Anu Chandra
    • 1
  • Farzana Mahdi
    • 1
  • Ajanta Roy
    • 1
  • Praveen Sharma
    • 1
    • 2
  1. 1.Department of BiochemistryEra’s Lucknow Medical College & HospitalLucknowIndia
  2. 2.Department of BiochemistrySMS Medical CollegeJaipurIndia

Personalised recommendations